These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 18720143)
1. Differential scanning calorimetry with curve-fitting program used to quantitatively analyze the polymorphic transformation of famotidine in the compressed compact. Cheng WT; Lin SY; Wang SL Drug Dev Ind Pharm; 2008 Dec; 34(12):1368-75. PubMed ID: 18720143 [TBL] [Abstract][Full Text] [Related]
2. Thermodynamic and kinetic characterization of polymorphic transformation of famotidine during grinding. Lin SY; Cheng WT; Wang SL Int J Pharm; 2006 Aug; 318(1-2):86-91. PubMed ID: 16647827 [TBL] [Abstract][Full Text] [Related]
3. Famotidine polymorphic transformation in the grinding process significantly depends on environmental humidity or water content. Cheng WT; Lin SY Int J Pharm; 2008 Jun; 357(1-2):164-8. PubMed ID: 18403143 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Fahmy RH; Kassem MA Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390 [TBL] [Abstract][Full Text] [Related]
5. An overview of famotidine polymorphs: solid-state characteristics, thermodynamics, polymorphic transformation and quality control. Lin SY Pharm Res; 2014 Jul; 31(7):1619-31. PubMed ID: 24577998 [TBL] [Abstract][Full Text] [Related]
6. Development of modified dosage form for enhancement of dissolution rate through amalgamation of solid dispersion and cube sugar or sintering technology using famotidine as a model drug. Gupta V; Gupta M; Madan AK PDA J Pharm Sci Technol; 2009; 63(1):58-70. PubMed ID: 19455942 [TBL] [Abstract][Full Text] [Related]
7. Polymorphic transformation of anhydrous caffeine under compression and grinding: a re-evaluation. Mazel V; Delplace C; Busignies V; Faivre V; Tchoreloff P; Yagoubi N Drug Dev Ind Pharm; 2011 Jul; 37(7):832-40. PubMed ID: 21214492 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the polymorphic modifications of famotidine. Hegedüs B; Bod P; Harsányi K; Péter I; Kálmán A; Párkányi L J Pharm Biomed Anal; 1989; 7(5):563-9. PubMed ID: 2490760 [TBL] [Abstract][Full Text] [Related]
9. Physico-chemical comparison of famotidine tablets prepared via dry granulation and direct compression techniques. Baseer A; Hassan F; Hassan SF; Jabeen S; Israr F; Murtaza G; Haque N Pak J Pharm Sci; 2013 May; 26(3):439-43. PubMed ID: 23625414 [TBL] [Abstract][Full Text] [Related]
11. The Slow Relaxation Dynamics in the Amorphous Pharmaceutical Drugs Cimetidine, Nizatidine, and Famotidine. Viciosa MT; Moura Ramos JJ; Diogo HP J Pharm Sci; 2016 Dec; 105(12):3573-3584. PubMed ID: 27773524 [TBL] [Abstract][Full Text] [Related]
12. Optimization and validation of a dissolution test for famotidine tablets using flow injection analysis. Tzanavaras PD; Verdoukas A; Balloma T J Pharm Biomed Anal; 2006 May; 41(2):437-41. PubMed ID: 16413732 [TBL] [Abstract][Full Text] [Related]
13. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy. Bellur Atici E; Karlığa B J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262 [TBL] [Abstract][Full Text] [Related]
14. Study of process induced polymorphic transformations in fluconazole drug. Desai SR; Dharwadkar SR Acta Pol Pharm; 2009; 66(2):115-22. PubMed ID: 19719043 [TBL] [Abstract][Full Text] [Related]
15. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy. Li Y; Chow PS; Tan RB Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601 [TBL] [Abstract][Full Text] [Related]
16. Process induced transformations during tablet manufacturing: phase transition analysis of caffeine using DSC and low frequency micro-Raman spectroscopy. Hubert S; Briancon S; Hedoux A; Guinet Y; Paccou L; Fessi H; Puel F Int J Pharm; 2011 Nov; 420(1):76-83. PubMed ID: 21884769 [TBL] [Abstract][Full Text] [Related]
17. Characterization of polymorphic ampicillin forms. Baraldi C; Tinti A; Ottani S; Gamberini MC J Pharm Biomed Anal; 2014 Nov; 100():329-340. PubMed ID: 25194347 [TBL] [Abstract][Full Text] [Related]
18. Famotidine, the new antiulcero-genic agent, a potent ligand for metal ions. Kozłowski H; Kowalik-Jankowska T; Anouar A; Decock P; Spychala J; Swiatek J; Ganadu ML J Inorg Biochem; 1992 Nov; 48(3):233-40. PubMed ID: 1333006 [TBL] [Abstract][Full Text] [Related]
19. [Analytical application of phosphotungstic acid complexes. Fabrication and characterisation of membrane selective electrodes for some H2 antihistaminics]. Apostu M; Dorneanu V Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):856-9. PubMed ID: 20201281 [TBL] [Abstract][Full Text] [Related]
20. The experimental electron density in polymorphs A and B of the anti-ulcer drug famotidine. Overgaard J; Hibbs DE Acta Crystallogr A; 2004 Sep; 60(Pt 5):480-7. PubMed ID: 15477688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]